BRNS vs MTCR
Comparison between Barinthus Biotherapeutics Plc. (BRNS, Company) and Metacrine Inc (MTCR, Company).
BRNS vs MTCR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BRNS
$25M
MTCR
$25M
Max Drawdown
Winner
BRNS
96.82%
MTCR
97.04%
Sharpe Ratio
BRNS
-1.03
Winner
MTCR
0.62
5Y Beta
BRNS
0.71
MTCR
N/A
Industry
BRNS
Biotechnology
MTCR
N/A
P/E Ratio
BRNS
-0.47
Winner
MTCR
-0.54
Debt to Equity
Winner
BRNS
0.00%
MTCR
37.20%
P/S Ratio
BRNS
3.80
MTCR
N/A
P/B Ratio
Winner
BRNS
0.37
MTCR
0.67
BRNS vs MTCR - Historical Returns
Returns include dividend reinvestment.
1M
BRNS
-13.62%
Winner
MTCR
+2.43%
3M
BRNS
-6.46%
Winner
MTCR
+2.41%
6M
BRNS
-22.67%
Winner
MTCR
+39.42%
1Y
BRNS
-63.19%
Winner
MTCR
+17.88%
5Y(CAGR)
BRNS
-47.65%
MTCR
N/A
Max(CAGR)
Winner
BRNS
-45.76%
MTCR
-66.40%
BRNS vs MTCR - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | BRNS | MTCR |
|---|---|---|
| 2026 | -22.37% | N/A |
| 2025 | -43.54% | N/A |
| 2024 | -67.35% | N/A |
| 2023 | +53.75% | +30.13% |
| 2022 | -78.87% | -36.01% |
| 2021 | -21.21% | -91.68% |
| 2020 | N/A | -33.16% |
BRNS vs MTCR Drawdown Comparison
The maximum drawdown for BRNS was -96.82%, occurring on Apr 1, 2026. This drawdown has not yet recovered.
The maximum drawdown for MTCR was -97.04%, occurring on Oct 24, 2022. This drawdown has not yet recovered.
The current BRNS drawdown is -96.64%. The current MTCR drawdown is -95.06%.
| Rank | BRNS | MTCR |
|---|---|---|
| #1 | -96.82% May 17, 2021 - Apr 1, 2026 | -97.04% Sep 16, 2020 - Oct 24, 2022 |
| #2 | -8.56% May 3, 2021 - May 12, 2021 | N/A |
Correlation
Correlation between BRNS and MTCR is 0.87 which considered as a strong positive correlation - the stocks tend to move together.
0.87
-101
Select Stocks to Compare
Popular: BRNS vs SPYMTCR vs SPY
More Comparisons
Compare with similar stocks